ShareValue scores for SBX.XETRA: Valuation 69, Quality 29, Growth 29, Health 42.
SBX.XETRAXETRA
SynBiotic SE
€1.08
(-1.28%)
SBX.XETRAXETRA
SynBiotic SE
€1.08(-1.28%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Weak
Growth:Weak
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
5% to 17%
Rating
Trap Risk
Return
5% to 17%
Valuation
69
Fair Value
Price vs Value
Quality
29
Weak
Business Strength
Growth
29
Weak
Revenue & Earnings
Health
42
Moderate
Financial Stability
Momentum
30
Bearish
Price Trend
Company Details
About
SynBiotic SE, together with its subsidiaries, engages in the pharmaceutical business in Germany and Europe. It is involved in the cultivation, research, development, production, and distribution of medicinal cannabis; industrial hemp; and cannabidiol and cannabinoid-based products. The company was incorporated in 2024 and is based in Düsseldorf, Germany.
Market Cap$8M
P/E RatioN/A
Dividend YieldNone
Sector Rank#2510
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026